Reasons for Distress Among Burn Survivors at 6, 12, and 24 Months Postdischarge: A Burn Injury Model System Investigation

Objective

To identify important sources of distress among burn survivors at discharge and 6, 12, and 24 months postinjury, and to examine if the distress related to these sources changed over time.

医院病理样本库管理系统的设计

目的:建立病理样本数据库,以规范病理样本管理流程,并为病理样本存储和研究提供工作平台。方法:病理样本库管理系统采用了J2EE、JSP及组件对象模型等技术,建立了病理样本库工作平台,实现了病理资源网络化、文档化及智能化。结果:该系统建立了病理样本管理系统架构和工作流程,为病理样本的收集、存储及分析提供了平台。结论:系统设计可提高样本检定结果的真实性和可信度,从而提高样本分析的准确性,为相关科室的信息化建设提供了良好的借鉴。     

金属冠脉支架磁共振适用性检测方法

目的:建立金属冠脉支架磁共振适用性实验平台,以实验室测试为基础,研究金属冠脉支架的磁共振适用性。方法:金属冠脉支架磁共振适用性试验分为四个部分,在3T磁共振环境下,分别进行磁位移力试验、磁扭矩试验、致热试验和图像干扰试验。结果:退磁效果好的金属冠脉支架,磁位移力小于其自身重力,磁扭矩小于其自身重力扭矩,温度升高值小,图像畸变值小。退磁效果不好的支架,磁位移力大于其自身重力,温度升高多,图像畸变值大。结论:实验平台可以对金属冠脉支架磁共振适用性进行检测,并对其退磁效果进行评价。     

神门、三阴交穴位配伍改善失眠症患者焦虑、抑郁状态：随机对照研究

目的:观察电针神门、三阴交对失眠症患者焦虑、抑郁状态的影响,并探索其配伍效应的作用机制。方法:将90例失眠症患者随机分为配伍组、神门组和三阴交组,每组30例,并进一步筛选出37例焦虑状态患者(配伍组12例、神门组13例、三阴交组12例)和42例抑郁状态患者(配伍组14例、神门组14例、三阴交组14例)。配伍组、神门组、三阴交组分别予电针神门-三阴交、神门单穴及三阴交单穴,疏密波,频率5 Hz/25 Hz,治疗每次30 min,每天1次,连续治疗5 d为一疗程,共治疗2个疗程。分别于治疗前后评定各组患者失眠严重程度指数(ISI)、焦虑自评量表(SAS)和抑郁自评量表(SDS)评分,检测血清多巴胺(DA)和去甲肾上腺素(NE)含量。结果:与治疗前比较,治疗后3组患者ISI、SAS、SDS评分均降低(P<0.05),配伍组ISI评分低于神门组(P<0.05)。治疗后,3组失眠症焦虑状态患者ISI、SAS评分及血清DA含量均较治疗前下降(P<0.05),配伍组、神门组患者血清NE较治疗前下降(P<0.05);配伍组、神门组患者SAS评分、血清NE含量及配伍组ISI评分低...     

注射用益气复脉（冻干）冲管液安全剂量测定

目的 测定注射用益气复脉（冻干）（YQFM）冲管液安全剂量。方法 以YQFM为研究对象,以0.9%氯化钠注射液为稀释剂和冲管溶液,采用紫外-可见分光光度法测定冲管液中主药成分残留,确定冲管液的安全剂量;收集各段冲管液,在冲管液中加入常用配伍药物呋塞米注射液,采用紫外-可见分光光度法对冲管安全剂量进行验证;在冲管液中加入注射用环磷酰胺,采用不溶性微粒检查法对冲管液安全剂量进行验证。结果 YQFM 0.9%氯化钠溶液特征吸收波长为203和283 nm,浓度-吸收趋势拟合显示线性良好;在0~300 min内稳定性较好;冲管速度为40滴/min（2 mL/min）时,YQFM冲管液安全剂量为32.0 mL/min,经验证冲管效果符合要求。结论 为保证临床用药的安全性,建议YQFM冲管液用剂量应不少于32.0 mL。     

Study of the water structure in poly(methyl methacrylate-block-2-hydroxyethyl methacrylate) and its relationship to platelet adhesion on the copolymer surface

The water structure and platelet compatibility of poly(methyl methacrylate (MMA)-block-2-hydroxyethyl methacrylate (HEMA)) were investigated. The molecular weight (Mn) of the polyHEMA segment was kept constant (average: 9600), while the Mn of the polyMMA segment was varied from 1340 to 7390. The equilibrium water content of the copolymers was found to be mainly governed by the HEMA content. The water structure in the copolymers was characterized in terms of the amounts of non-freezing and freezing water (abbreviated as W_nf and W_fz, respectively) using differential scanning calorimetry. It was found that the W_nf for the copolymers were higher than those estimated from the W_nf for the HEMA and MMA homopolymers and that the amount of excess non-freezing water depended on the polyMMA segment length. In addition, X-ray diffraction analysis revealed that some of the copolymers had cold-crystallizable water. These facts suggested that the polyMMA segments were involved in determining the water structures in the copolymers. Furthermore, the platelet compatibility of the copolymers was improved as compared to that of the HEMA homopolymer. It was therefore concluded that the platelet compatibility of the copolymer was related to the amount of excess non-freezing water.     

Modification of Polyurethane with Polyethylene Glycol–Corn Trypsin Inhibitor for Inhibition of Factor Xlla in Blood Contact

Abstract

In previous work using gold as a model substrate, we showed that modification of surfaces with poly(ethylene glycol) (PEG) and corn trypsin inhibitor (CTI) rendered them protein resistant and inhibitory against activated factor XII. Sequential attachment of PEG followed by CTI gave superior performance compared to direct attachment of a preformed PEG-CTI conjugate. In the present work, a sequential method was used to attach PEG and CTI to a polyurethane (PU) substrate to develop a material with applicability for blood-contacting medical devices. Controls included surfaces modified only with PEG and only with CTI. Surfaces were characterized by water contact angle and X-ray photoelectron spectroscopy. The surface density of CTI was in the range of a monolayer and was higher on the PU substrate than on gold reported previously. Biointeractions were investigated by measuring fibrinogen adsorption from buffer and plasma, factor XIIa inhibition and plasma clotting time. Both the PU–PEG surfaces and the PU–PEG–CTI surfaces showed low fibrinogen adsorption from buffer and plasma, indicating that PEG retained its protein resistance when conjugated to CTI. Although the CTI density was lower on PU–PEG–CTI than on PU modified only with CTI, PU–PEG–CTI exhibited greater factor XIIa inhibition and a longer plasma clotting time, suggesting that PEG facilitates the interaction of CTI with factor XIIa. Thus sequential attachment of PEG and CTI may be a useful approach to improve the thromboresistance of PU surfaces.     

Blood compatibility of polypropylene surfaces in relation to the crystalline-amorphous microstructure

Blood-contacting properties of polypropylene surfaces with different crystalline states at the surface layer were examined in terms of plasma protein adsorption and changes in cytoplasmic free Ca²⁺ levels in platelets. Though the wettability of polypropylene surfaces was almost constantly independent from the surface layer crystallinity and interlamellar spacing, an increase in adhesiveness was observed with decreasing surface layer crystallinity and interlamellar spacing. It is suggested that the surface properties of the sheets varied in relation to the crystalline-amorphous microstructure. Minimum magnitudes in albumin and fibrinogen adsorption were observed on the polypropylene surface with a particular surface layer crystallinity (c. 55 wt%). A decrease in interlamellar spacing resulted in enhancing albumin adsorption and diminishing fibrinogen adsorption. Transient phenomena in plasma protein adsorption were observed on their surfaces with a plasma concentration. It is considered that the polypropylene surface with a particular crystalline-amorphous microstructure reduces the denaturation of adsorbed proteins. An increase in cytoplasmic free Ca²⁺ levels in platelets was prevented at the polypropylene surface with a surface layer crystallinity of 55 wt%: the particular crystalline-amorphous microstructure of such apolar surfaces as polypropylenes acts to reduce platelet activation. Thus, it is concluded that the blood compatibility of polypropylene surfaces is greatly improved by controlling a crystalline-amorphous microstructure at the surface layer.     

Surface studies of albumin immobilized onto PE and PVC films

The aim of this study is to evaluate the thrombogenic behaviour of the low density polyethylene and poly(vinyl chloride) modified by radiation-grafting technique. After copolymerization with acrylic acid by y-rays from a ⁶⁰Co source, BSA was immobilized onto functionalized graft copolymers. The biological interaction between these materials and blood was studies by in vitro methods. The BSA immobilization effectively suppressed the adhesion and activation of platelets when it contacted whole blood.     

UPLC法同时测定柴胡疏肝散水煎液冻干物中8个成分的含量

目的:建立柴胡疏肝散水煎液冻干物中8个成分含量同时测定的方法。方法:采用超高效液相色谱法对6批柴胡疏肝散水煎液冻干物样品中8个成分芍药内酯苷、芍药苷、阿魏酸、柚皮苷、橙皮苷、苯甲酰芍药苷、甘草酸、α-香附酮进行含量测定。色谱柱为Phenomenex,流动相为0.1%甲酸水-乙腈梯度洗脱,检测波长为250 nm,柱温为30℃,流速为1 mL/min,进样体积为10μL。结果:芍药内酯苷、芍药苷、阿魏酸、柚皮苷、橙皮苷、苯甲酰芍药苷、甘草酸、α-香附酮的检测质量浓度线性范围分别3.606~8.414、23.988~55.972、1.218~2.842、35.964~83.916、12.009~28.021、1.194~2.786、3.609~8.421、5.294~12.352μg/mL(r=0.999 5~0.999 9),定量限分别为0.206、0.178、0.256、0.168、0.196、0.242、0.268、0.157μg/mL;精密度试验、稳定性试验(12 h)、重复性试验中的RSD均<2%(n=5或6),回收率分别为97.93%、98.18%、96.57%、97.61%、98.51%、97.45%、98.14%、96.91%(RSD均<2%);6批样品中芍药内酯苷、芍药苷、阿魏酸、柚皮苷、橙皮苷、苯甲酰芍药苷、甘草酸的平均含量分别为59.258、429.237、23.173、625.847、200.424、15.048、67.620μg/g,α-香附酮因具有挥发性未检测出。结论:建立的含量测定方法简便,结果稳定、可靠、准确,可为柴胡疏肝散水煎液冻干物的质量控制提供参考。